[go: up one dir, main page]

DK0920539T3 - Fremgangsmåder til detektion af nukleinsyresekvenser i urin - Google Patents

Fremgangsmåder til detektion af nukleinsyresekvenser i urin

Info

Publication number
DK0920539T3
DK0920539T3 DK98924998T DK98924998T DK0920539T3 DK 0920539 T3 DK0920539 T3 DK 0920539T3 DK 98924998 T DK98924998 T DK 98924998T DK 98924998 T DK98924998 T DK 98924998T DK 0920539 T3 DK0920539 T3 DK 0920539T3
Authority
DK
Denmark
Prior art keywords
nucleic acid
acid sequence
urine
urine sample
acid sequences
Prior art date
Application number
DK98924998T
Other languages
English (en)
Inventor
Anatoly V Lichtenstein
Hovsep S Melkonyan
Samuil R Umansky
Original Assignee
Xenomics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xenomics filed Critical Xenomics
Application granted granted Critical
Publication of DK0920539T3 publication Critical patent/DK0920539T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6879Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for sex determination
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/14Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333Saccharide [e.g., DNA, etc.]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK98924998T 1997-05-30 1998-05-29 Fremgangsmåder til detektion af nukleinsyresekvenser i urin DK0920539T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4817097P 1997-05-30 1997-05-30
US4838197P 1997-06-30 1997-06-30

Publications (1)

Publication Number Publication Date
DK0920539T3 true DK0920539T3 (da) 2006-07-24

Family

ID=26725864

Family Applications (3)

Application Number Title Priority Date Filing Date
DK05077010.6T DK1634966T3 (da) 1997-05-30 1998-05-29 Fremgangsmåder til detektering af nukleinsyresekvenser i urin
DK98924998T DK0920539T3 (da) 1997-05-30 1998-05-29 Fremgangsmåder til detektion af nukleinsyresekvenser i urin
DK10161334.7T DK2216416T3 (da) 1997-05-30 1998-05-29 Fremgangsmåder til detektering af nukleinsyresekvenser i urin

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK05077010.6T DK1634966T3 (da) 1997-05-30 1998-05-29 Fremgangsmåder til detektering af nukleinsyresekvenser i urin

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK10161334.7T DK2216416T3 (da) 1997-05-30 1998-05-29 Fremgangsmåder til detektering af nukleinsyresekvenser i urin

Country Status (10)

Country Link
US (2) US6251638B1 (da)
EP (3) EP1634966B1 (da)
AT (3) ATE486958T1 (da)
AU (1) AU7703998A (da)
CY (1) CY1113124T1 (da)
DE (2) DE69841989D1 (da)
DK (3) DK1634966T3 (da)
ES (3) ES2260837T3 (da)
PT (1) PT2216416E (da)
WO (1) WO1998054364A1 (da)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6451523B1 (en) * 1994-09-14 2002-09-17 Interneuron Pharmaceuticals, Inc. Detection of a leptin receptor variant and methods for regulating obesity
ES2324503T3 (es) 1997-04-10 2009-08-07 Stichting Katholieke Universiteit University Medical Centre Nijmegen Pca3, genes pca3 y metodos de uso.
USRE39920E1 (en) * 1997-05-30 2007-11-13 Xenomics, Inc. Methods for detection of nucleic acid sequences in urine
US7060458B1 (en) * 1997-08-14 2006-06-13 Wyeth Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics
US20030166107A1 (en) * 1997-09-18 2003-09-04 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7569342B2 (en) 1997-12-10 2009-08-04 Sierra Molecular Corp. Removal of molecular assay interferences
US20030068731A1 (en) * 1997-12-17 2003-04-10 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20030113842A1 (en) * 1998-03-11 2003-06-19 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7339033B2 (en) * 1998-06-26 2008-03-04 Genentech, Inc. Pro1481
US7538086B2 (en) * 1998-09-01 2009-05-26 Genentech, Inc. PRO1303 polypeptides
WO2001009324A1 (fr) * 1999-07-30 2001-02-08 Mitsubishi Pharma Corporation Gene de pgt de type cerveau humain
JP4018304B2 (ja) * 1999-08-27 2007-12-05 独立行政法人科学技術振興機構 高親和性コリントランスポーター
JP2003510075A (ja) * 1999-09-29 2003-03-18 ディグノキュアー・インコーポレーテッド 良性および悪性の前立腺組織におけるpca3メッセンジャーrna種
EP1201681A1 (en) * 2000-10-30 2002-05-02 Millennium Pharmaceuticals, Inc. "Fail" molecules and uses thereof
AU2002243263A1 (en) * 2000-11-15 2002-07-24 Roche Diagnostics Corporation Methods and reagents for identifying rare fetal cells in the material circulation
US7029840B2 (en) * 2000-11-15 2006-04-18 Becton, Dickinson And Company Method for preservation of cells and nucleic acid targets
WO2002059316A2 (en) * 2001-01-23 2002-08-01 Lexicon Genetics Incorporated Human ion exchanger proteins and polynucleotides encoding the same
US20030144196A1 (en) * 2001-08-21 2003-07-31 Bowen Michael A. Activated T lymphocyte nucleic acid sequences and polypeptides encoded by same
JP2005514956A (ja) * 2002-01-18 2005-05-26 ジェンザイム・コーポレーション 胎児dnaの検出および対立遺伝子の定量化のための方法
WO2003071252A2 (en) 2002-02-15 2003-08-28 Exact Sciences Corporation Methods for analysis of molecular events
US7217515B2 (en) * 2002-09-30 2007-05-15 Chi Mei Foundation Medical Center HURP gene as a molecular marker for bladder cancer
CA2445204C (en) 2002-10-16 2014-08-12 Streck Laboratories, Inc. Method and device for collecting and preserving cells for analysis
JP4824540B2 (ja) 2003-02-07 2011-11-30 ダイアノキュアー インク. サンプル中の前立腺癌を検出する方法
EP1584923A3 (en) * 2004-04-07 2006-01-04 Roche Diagnostics GmbH Stabilization of biomolecules in samples
US20080241827A1 (en) * 2004-05-10 2008-10-02 Exact Sciences Corporation Methods For Detecting A Mutant Nucleic Acid
BRPI0513692B8 (pt) 2004-07-23 2021-07-27 Pacific Edge Biotechnology Ltd processos para detecção de câncer de bexiga em um indivíduo
WO2006026654A2 (en) * 2004-08-27 2006-03-09 Exact Sciences Corporation Method for detecting a recombinant event
WO2006047481A2 (en) 2004-10-22 2006-05-04 Redpath Integrated Pathology, Inc. Enhanced amplifiability of minute fixative-treated tissue samples, minute stained cytology samples, and other minute sources of dna
US9109256B2 (en) 2004-10-27 2015-08-18 Esoterix Genetic Laboratories, Llc Method for monitoring disease progression or recurrence
CA2491067A1 (en) 2004-12-24 2006-06-24 Stichting Katholieke Universiteit Mrna rations in urinary sediments and/or urine as a prognostic marker for prostate cancer
AU2006214444B8 (en) 2005-02-17 2012-04-05 Trovagene, Inc. Compositions and methods for detecting pathogen specific nucleic acids in urine
ITRM20050067A1 (it) 2005-02-17 2006-08-18 Istituto Naz Per Le Malattie I Metodo per la rivelazione di acidi nucleici virali o di origine virale nelle urine.
ITRM20050068A1 (it) 2005-02-17 2006-08-18 Istituto Naz Per Le Malattie I Metodo per la rivelazione di acidi nucleici di agenti patogeni batterici o di parassiti nelle urine.
US7914982B2 (en) 2005-02-17 2011-03-29 Trovagene, Inc. Methods for detecting pathogen specific nucleic acids in urine
US7449297B2 (en) * 2005-04-14 2008-11-11 Euclid Diagnostics Llc Methods of copying the methylation pattern of DNA during isothermal amplification and microarrays
US9777314B2 (en) * 2005-04-21 2017-10-03 Esoterix Genetic Laboratories, Llc Analysis of heterogeneous nucleic acid samples
NZ545243A (en) 2006-02-10 2009-07-31 Pacific Edge Biotechnology Ltd Urine gene expression ratios for detection of cancer
WO2008070862A2 (en) * 2006-12-07 2008-06-12 Biocept, Inc. Non-invasive prenatal genetic screen
WO2008075790A2 (en) * 2006-12-20 2008-06-26 Olympus Corporation Method for detecting cancer with nucleic acids in blood
CN101861399B (zh) * 2007-08-22 2015-11-25 特罗瓦基因公司 使用miRNA检测体内细胞死亡情况的方法
WO2009049147A2 (en) * 2007-10-10 2009-04-16 Philadelphia Health & Education Corporation D/B/A Drexel University College Of Medicine Method of tumor screening by detection of tumour marker in low molecular weight nucleic acid from urine
CN101999003A (zh) * 2008-02-12 2011-03-30 诺瓦蒂斯公司 分离无细胞凋亡或胎儿核酸的方法
EP2271772B1 (en) * 2008-03-11 2014-07-16 Sequenom, Inc. Nucleic acid-based tests for prenatal gender determination
ES2532153T3 (es) 2008-07-18 2015-03-24 Trovagene, Inc. Métodos para la detección de secuencias de ácidos nucleicos "ultracortos" basados en PCR
US8476013B2 (en) 2008-09-16 2013-07-02 Sequenom, Inc. Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
US8962247B2 (en) * 2008-09-16 2015-02-24 Sequenom, Inc. Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses
US11634747B2 (en) * 2009-01-21 2023-04-25 Streck Llc Preservation of fetal nucleic acids in maternal plasma
EP3290530B1 (en) 2009-02-18 2020-09-02 Streck Inc. Preservation of cell-free nucleic acids
WO2011057184A1 (en) * 2009-11-09 2011-05-12 Streck, Inc. Stabilization of rna in and extracting from intact cells within a blood sample
EP2516680B1 (en) 2009-12-22 2016-04-06 Sequenom, Inc. Processes and kits for identifying aneuploidy
US8460872B2 (en) 2011-04-29 2013-06-11 Sequenom, Inc. Quantification of a minority nucleic acid species
EP2704740B1 (en) 2011-05-04 2016-10-05 Streck, Inc. Inactivated swine flu virus and methods of preparing it
KR101489568B1 (ko) 2011-06-29 2015-02-03 비지아이 헬스 서비스 코포레이션 리미티드 태아 유전학적 이상의 비침습성 검출
US9605313B2 (en) 2012-03-02 2017-03-28 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US9920361B2 (en) 2012-05-21 2018-03-20 Sequenom, Inc. Methods and compositions for analyzing nucleic acid
US10504613B2 (en) 2012-12-20 2019-12-10 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
EP2872648B1 (en) 2012-07-13 2019-09-04 Sequenom, Inc. Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
US9341628B2 (en) 2012-11-30 2016-05-17 Interpace Diagnostics Corporation Methods for measuring carcinoembryonic antigen
EP3597774A1 (en) 2013-03-13 2020-01-22 Sequenom, Inc. Primers for dna methylation analysis
EP4136972A1 (en) 2013-07-24 2023-02-22 Streck, Inc. Compositions and methods for stabilizing circulating tumor cells
EP3117011B1 (en) 2014-03-13 2020-05-06 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US10435750B2 (en) 2014-07-03 2019-10-08 Multiplicom N.V. Methods for non-invasive detection of transplant health or rejection
US11168351B2 (en) 2015-03-05 2021-11-09 Streck, Inc. Stabilization of nucleic acids in urine
US20170145475A1 (en) 2015-11-20 2017-05-25 Streck, Inc. Single spin process for blood plasma separation and plasma composition including preservative
US11506655B2 (en) 2016-07-29 2022-11-22 Streck, Inc. Suspension composition for hematology analysis control
WO2018064486A1 (en) 2016-09-29 2018-04-05 Counsyl, Inc. Noninvasive prenatal screening using dynamic iterative depth optimization
ES2991437T3 (es) 2017-10-19 2024-12-03 Streck Llc Composiciones para la regulación de la hemólisis y la coagulación y la estabilización de vesículas extracelulares
US12270072B2 (en) 2018-06-07 2025-04-08 Biofire Diagnostics, Llc Rapid thermocycling methods
US11965217B2 (en) * 2020-07-21 2024-04-23 Delta Electronics, Inc. Method and kit for detecting Mycobacterium tuberculosis
US20240018585A1 (en) * 2020-12-15 2024-01-18 Gateway Genomics, Llc Methods, compositions, and devices for the rapid determination of fetal sex

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US5541331A (en) 1991-04-30 1996-07-30 Reilly Industries, Inc. Processes for producing α-pyridyl carbinols
US6020124A (en) * 1992-04-27 2000-02-01 Trustees Of Dartmouth College Detection of soluble gene sequences in biological fluids
EP0655090B1 (en) 1992-04-27 2000-12-27 The Trustees Of Dartmouth College Detection of gene sequences in biological fluids
US5541311A (en) 1992-12-07 1996-07-30 Third Wave Technologies, Inc. Nucleic acid encoding synthesis-deficient thermostable DNA polymerase
US5614402A (en) 1992-12-07 1997-03-25 Third Wave Technologies, Inc. 5' nucleases derived from thermostable DNA polymerase
WO1997006819A1 (en) * 1995-08-15 1997-02-27 Alteon Inc. Compositions and methods for elmination of advanced glycosylation endproducts (in vivo)
DE19540222A1 (de) * 1995-10-18 1997-04-24 Horst Dr Schlechte Verfahren und Vorrichtung zur Gewinnung Personen- und Krankheits-spezifischer Nucleinsäure-Sequenz-Daten
CA2243353C (en) 1996-01-24 2010-03-30 Third Wave Technologies, Inc. Invasive cleavage of nucleic acids

Also Published As

Publication number Publication date
EP2216416B1 (en) 2012-05-09
EP0920539A1 (en) 1999-06-09
WO1998054364A1 (en) 1998-12-03
DE69841989D1 (de) 2010-12-16
CY1113124T1 (el) 2016-04-13
ATE320505T1 (de) 2006-04-15
AU7703998A (en) 1998-12-30
ES2389055T3 (es) 2012-10-22
ATE486958T1 (de) 2010-11-15
PT2216416E (pt) 2012-08-16
DK2216416T3 (da) 2012-08-27
EP2216416A1 (en) 2010-08-11
EP1634966B1 (en) 2010-11-03
US6251638B1 (en) 2001-06-26
ES2355631T3 (es) 2011-03-29
DE69833856T2 (de) 2006-11-23
EP0920539A4 (en) 2004-06-09
DE69833856D1 (de) 2006-05-11
DK1634966T3 (da) 2011-02-07
US6287820B1 (en) 2001-09-11
ES2260837T3 (es) 2006-11-01
EP1634966A3 (en) 2006-06-21
EP1634966A2 (en) 2006-03-15
ATE557103T1 (de) 2012-05-15
EP0920539B1 (en) 2006-03-15
EP0920539B9 (en) 2006-08-02
HK1088363A1 (en) 2006-11-03

Similar Documents

Publication Publication Date Title
DK2216416T3 (da) Fremgangsmåder til detektering af nukleinsyresekvenser i urin
DK1141728T3 (da) Påvisning af nyresygdom og behandling deraf
DE69333289D1 (de) Verfahren zur bestimmung von säugetier nukleinsäuren aus stuhlproben und dafür benötigte reagenzien
ATE515693T1 (de) Nachweis einer zielsubstanz in einer probe
EP1318399A3 (en) Passive sample detection to initiate timing of an assay
DE60000583D1 (de) Verfahren zur identifizierung und/oder quantifizierung einer zielverbindung
FI901917A7 (fi) Menetelmä nukleiinihapon uuttamiseksi amplifioimiseksi ja havaitsemiseksi kokoverestä tai PMBC-jakeesta
WO2002006511A3 (en) Methods for detecting and assaying nucleic acid sequences
ATE403153T1 (de) Test zum direkten nachweisen einer rs virus bezogenen biologischen zelle in einer körperflüssigkeitsprobe
DE69911007D1 (de) Nukleinsäuresequenzidentifizierung
CA2317816A1 (en) Peptide detection method
DK0696642T3 (da) Fremgangsmåde til påvisning af forstyrrelser i protein C/protein S-systemet
AU4663997A (en) Detection and identification of non-polio enteroviruses
DK328584D0 (da) Immunobestemmelsesmetode for en iodthyronin i en biologisk vaeske samt reagenssystem, testsaet og testmateriale til anvendelse ved metoden
NO994705L (no) Preparering av blodpröver for deteksjon av homocystein og/eller folat
ATE449868T1 (de) Methoden, testsätze und kompositionen zur detektion und quantifizierung von zielsequenzen
RU2007148219A (ru) Способ обнаружения бактерий и тест-набор для их обнаружения
WO2001090408A3 (fr) Detection et caracterisation de l'activite de proteines impliquees dans la reparation de lesions de l'adn
DK0729518T3 (da) Primere og prober til amplifikation og detektion af CMV-nukleinsyre
EP1136568A4 (en) METHOD FOR DETERMINING NUCLEIC ACID
ATE386140T1 (de) Methoden und reagenzien zur in situ amplifizierung
Martin et al. A comparative study of the citrate and lactate concentrations in stains from semen, vaginal secretion and mixtures of the two using isotachophoresis
EP1398378A4 (en) IN NEUROBLASTOM ISOLATED NUCLEIC ACIDS
WO2002018661A3 (en) Methods for identifying novel therapeutic agents
DE60136572D1 (de) Detektion von rpob sequenzen von mycobacterium tuberculosis